European Centre for Disease Prevention and Control

1. European Centre for Disease Prevention and Control ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Stockholm, May 2012

2. ECDC prevalence survey of healthcare-associated infections and antimicrobial use Form H.Hospital data Hospital code: Survey dates: From __ / __ /____ To: __ / __ / ____ dd/mm/yyyydd/mm/yyyy Hospital size (total number of beds) Number of acute care beds Number of ICU beds Exclusion of wards for PPS? No Yes (please specify which ward types were excluded) _______________________________________________ _______________________________________________ Total number of beds in included wards: Total number of patients included in PPS: Hospital type: primary secondary tertiary specialised; please indicate specialisation type: ____________________________ (1) Data were collected forincluded wards (Inc = recommended) or for the total hospital (Tot); if all wards were included in PPS (Inc Tot), mark “Inc”. FTE = full-time equivalent Data apply to: Single hospital or hospital site Hospital trust or chain PPS Protocol: StandardLight Comments/observations: ___________________________ ______________________________________________ ______________________________________________ ______________________________________________ Below: To be filled in/checked by national coordinator Is the hospital part of a national representative sample of hospitals? No Yes Unknown

3. ECDC prevalence survey of healthcare-associated infections and antimicrobial use Form A.Patient-based data (standard protocol) Patient data (to collect for all patients) • Hospital code • Ward name (abbreviated)/Unit ID • Ward specialty • Survey date: ___ / ___ / _______ (dd/mm/yyyy) • Patient counter: _________________________________ • Age in years: ____ years; age if < 2 years old: _____ months • Sex: M F • Date of hospital admission: ___ / ___ / _____ (dd/mm/yyyy) • Consultant/patient specialty: • Surgery since admission: • O No surgery O Minimal invasive/non-NHSN surgery • O NHSN surgeryO Unknown • McCabe score: • O Non-fatal disease O Ultimately fatal disease • O Rapidly fatal disease O Unknown • Central vascular catheter: • Peripheral vascular catheter: • Urinary catheter: • Intubation: • Patient receives antimicrobial(s)(1): • Patient has active HAI(2): Route: P: parenteral, O: oral, R: rectal, I: inhalation. Indication: CI - LI - HI: treatment intention for community-acquired (CI), long-/intermediate-term care-acquired (LI), or acute hospital-acquired infection (HI); surgical prophylaxis: SP1: single dose, SP2: one day, SP3: > one day; MP: medical prophylaxis; O: other; UI: unknown indication. Diagnosis: see site list, only for treatment intention. Reason in notes: Y/N. O No O Yes O Unk O No O Yes O Unk O No O Yes O Unk O No O Yes O Unk O No O Yes O Unk O No O Yes O Unk IF YES (1) At the time of the survey, except for surgical prophylaxis 24 hours before 8 a.m. on the day of the survey; if yes, fill in antimicrobial use data; (2) [infection with onset ≥ Day 3, OR SSI criteria met (surgery in previous 30 days/1 year), OR discharged from acute care hospital < 48 hours ago, OR CDI and discharged from acute care hospital < 28 days ago OR onset < Day 3 after invasive device/procedure on D1 or D2] AND [HAI case criteria met on survey day OR patient is receiving (any) treatment for HAI AND case criteria are met between D1 of treatment and survey day]; if yes, fill in HAI data. (3) Relevant device use (intubation for PN, CVC/PVC for BSI, urinary catheter for UTI) within 48 hours before onset of infection (even intermittent use), seven days for UTI. (4) Only for infections not present/active at admission (dd/mm/yyyy). (5) C-CVC, C-PVC, S-PUL, S-UTI, S-DIG, S-SSI, S-SST, S-OTH, UO, UNK. (6) AMR marker 0, 1, 2 or 9, see table.

4. ECDC prevalence survey of healthcare-associated infections and antimicrobial use Form B1.Ward denominator data (light protocol) Survey date1: ___ / ___ / _______ (dd/mm/yyyy) Hospital code Ward name (abbreviated)/Unit IDWard specialty2 Total number of patients in ward3 Number of patients by consultant/patient specialty: 1 Patients on the same ward should be included on a single day if possible. 2 Main ward specialty: ≥ 80% of patients belong to this specialty, otherwise choose mixed ward. 3 Admitted to the ward before or at 8 a.m. and not discharged from the ward at time of the survey.

5. ECDC prevalence survey of healthcare-associated infections and antimicrobial use Form B2.Antimicrobial use and HAI data (light protocol) Patient data (patients with HAI and/or antimicrobial only) Hospital code Ward name (abbreviated)/Unit ID Patient counter: _________________________________ Age in years: ____ years; age if < 2 years old: _____ months Sex: M F Date of hospital admission: ___ / ___ / _____ (dd/mm/yyyy) Consultant/patient specialty: Patient receives antimicrobial(s)(1): O No O Yes Patient has active HAI(2): O No O Yes Route: P: parenteral, O: oral, R: rectal, I: inhalation. Indication: CI - LI - HI: treatment intention for community-acquired (CI), long-/intermediate-term care-acquired (LI), or acute hospital-acquired infection (HI); surgical prophylaxis: SP1: single dose, SP2: one day, SP3: > 1day; MP: medical prophylaxis; O: other; UI: unknown indication. Diagnosis: see site list, only for treatment intention. Reason in notes: Y/N. IF YES (1) At the time of the survey, except for surgical prophylaxis 24 hours before 8 a.m. on the day of the survey; if yes, fill antimicrobial use data; (2) [infection with onset ≥ Day 3, OR SSI criteria met (surgery in previous 30 days/1year), OR discharged from acute care hospital < 48 hours ago, OR CDI and discharged from acute care hospital < 28 days ago OR onset < Day 3 after invasive device/procedure on D1 or D2] AND [HAI case criteria met on survey day OR patient is receiving (any) treatment for HAI AND case criteria are met between D1 of treatment and survey day]; if yes, fill in HAI data. (3) Relevant device use (intubation for PN, CVC/PVC for BSI, urinary catheter for UTI) within 48 hours before onset of infection (even intermittent use), seven days for UTI; (4) Only for infections not present/active at admission (dd/mm/yyyy); (5) C-CVC, C-PVC, S-PUL, S-UTI, S-DIG, S-SSI, S-SST, S-OTH, UO, UNK; (6) AMR marker 0,1,2 or 9; see table.

6. ECDC prevalence survey of healthcare-associated infections and antimicrobial use Form N.National/regional data Country code: _____ Network ID/data source: _____ Start date PPS: __ / __ /____ (dd/mm/yyyy) National/regional PPS coordination centre/institute: ___________________________________________________ National/regional PPS coordination programme/unit: Name: ____________________________________________ Website: __________________________________________ Method of sampling/recruitment of hospitals (more than one answer possible): O representative systematic random sample O other representative sample O convenience sample (selection) O all hospitals invited O voluntary participation O mandatory participation Total number of hospitals in PPS: Light (unit-based) protocol ____ Standard (patient-based) protocol _____ Number of hospitals submitted to ECDC: Light (unit-based) protocol ____ Standard (patient-based) protocol _____ Comments/observations: _________________________________________________________________________________________ ______________________________________________________________________________________________________________ ______________________________________________________________________________________________________________